Properties of prostaglandin E1.
Sinzinger
H
H
Kritz
H
H
D000527:Alprostadil / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D004285:Dogs; D004730:Endothelium, Vascular / Q000293:injuries*; D006801:Humans; D008081:Liposomes; D010974:Platelet Aggregation / Q000187:drug effects; D012107:Research Design; D013045:Species Specificity; D014665:Vasodilator Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use
D008081:Liposomes; D014665:Vasodilator Agents; D000527:Alprostadil